皮肤性病诊疗学杂志2025，Vol.32Issue(4)：233-239,7.DOI:10.3969/j.issn.1674-8468.2025.04.001
孕期HSV感染管理的国际进展:2024年英国指南解读与中国实践比较
Interpretation of the 2024 BASHH & RCOG UK guideline on HSV management in preg-nancy:key recommendations and comparison with Chinese clinical practice
摘要
Abstract
Herpes simplex virus(HSV)types 1 and 2 pose significant health risks during pregnancy,im-pacting both maternal and neonatal outcomes.The 2024 joint guideline from the British Association for Sexual Health and HIV(BASHH)and the Royal College of Obstetricians and Gynaecologists(RCOG)in the United Kingdom introduces updated recommendations to reduce maternal-to-neonatal transmission.Key recommenda-tions include initiating antiviral therapy earlier—at 32 weeks for standard pregnancies or as early as 22 weeks in high-risk cases—to minimize viral shedding.The guideline emphasizes polymerase chain reaction(PCR)testing for accurate diagnosis and advocates a multidisciplinary team(MDT)approach,involving genitourinary medicine(GUM)specialists,obstetricians,and neonatologists for delivery planning and neonatal care.How-ever,the Chinese guidelines offer greater flexibility in the timing of antiviral treatment,tailored to regional re-sources and specific circumstances.PCR testing is also recommended,particularly in urban hospitals and terti-ary care settings.The UK's MDT model aligns with China's integrative healthcare approach,presenting oppor-tunities for mutual learning and collaboration.This comparative analysis highlights areas for cross-adaptation in clinical practices,with potential to enhance maternal and neonatal health outcomes globally.关键词
单纯疱疹病毒/妊娠/孕产妇健康/英国BASHH和RCOG指南/多学科协作/临床实践比较Key words
HSV/pregnancy/maternal health/BASHH & RCOG UK guideline/multidisciplinary approach/comparative clinical practice引用本文复制引用
飞瑞塔,陈钊琪,柯吴坚..孕期HSV感染管理的国际进展:2024年英国指南解读与中国实践比较[J].皮肤性病诊疗学杂志,2025,32(4):233-239,7.基金项目
National Natural Science Foundation of China(82072321) （82072321）
Guangdong Natural Science Foundation(2025A1515011165) 国家自然科学基金(82072321) （2025A1515011165）
广东省自然科学基金(2025A1515011165) （2025A1515011165）
